Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Clinical trial results for early GLP-1 receptor agonist and SGLT2 inhibitor add-on strategies in adults with obesity, type 2 diabetes, cardi…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Identification and Characterization of At-risk MASLD in Turkish Adults
This completed clinical trial identifies and characterizes individuals at risk for Metabolic dysfunction-associated steatotic liver disease …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD
A clinical trial update describes using ultrasound-derived fat fraction and 2D/4D HeartAI to manage cardiovascular risk in MASLD patients, w…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) [Phase 4]
Phase 4 clinical trial comparing an early time-restricted eating Mediterranean diet to naltrexone/bupropion for liver fibrosis in adults wit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Guerbet Liver Fibrosis
Clinical trial update indicating enrollment-by-invitation for a Guerbet Liver Fibrosis study sponsored by Icahn School of Medicine at Mount …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Risk Factors and Prediction Model for Liver-Related Outcomes in Elderly Patients With Steatotic Liver Disease
The clinical trial update identifies risk factors and presents a prediction model for liver-related outcomes in elderly patients with steato…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [Phase 1, Phase 2]
An early-phase study to evaluate the safety and tolerability of ALN-PNP in healthy adults and adults with MASLD, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH) [Phase 1]
Regeneron is evaluating ALN-CIDEB in a Phase 1 study in adults with metabolic dysfunction-associated steatotic liver disease or metabolic dy…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
This clinical trial entry describes a study comparing S-Viscosity and Canon Dispersion Slope in metabolic dysfunction-associated steatotic l…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Time-restricted Feeding in MASLD [NA]
This clinical trial update notes a study on time-restricted feeding for Metabolic dysfunction-associated steatotic liver disease (MASLD) tha…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD [Phase 2]
A Phase 2a trial evaluating ALN-PNP with and without a GLP-1 receptor agonist for homozygous PNPLA3-related MASLD is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: The Impact of Nutrition Education and Rice Bran Supplementation on Metabolic Dysfunction-associated Steatotic Liver Disease [NA]
A completed clinical trial evaluating the impact of nutrition education and rice bran supplementation on Metabolic dysfunction-associated st…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Phase 2 clinical trial evaluating accurate point-of-careDiagnostics for liver disease, currently recruiting. Sponsored by the University of …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Non-Invasive Diagnostic Tests for MASLD in Pediatric Population [NA]
Emory University is conducting an active-not-recruiting study evaluating non-invasive diagnostic tests for Metabolic Dysfunction-Associated …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index [Phase 2]
Phase 2 trial investigating tauroursodeoxycholic acid (TUDCA) in high‑risk lactating mothers identified by an early postpartum milk hydropho…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial assessing the impact of an SGLT2 inhibitor on metabolic dysfunction-associated steatotic liver disease in adults with type 2 d…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
A clinical trial is evaluating probiotic supplementation with lifestyle modification on liver steatosis, fibrosis, and metabolic health in M…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Effect of Plant-based Diets on Liver Biomarkers, Cardiometabolic Health, and Exposure to Environmental Contaminants and Endocrine Disruptors in Patients With Metabolic Liver Disease. [NA]
This clinical trial investigates the effects of plant-based diets on liver biomarkers, cardiometabolic health, and exposure to environmental…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes [NA]
This clinical trial update notes a NOT_YET_RECRUITING study evaluating screening for MASLD-related advanced liver fibrosis in people with ty…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD [NA]
A clinical trial from Hospices Civils de Lyon is assessing gut microbiota–derived amino acid metabolite production in patients with MASLD an…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Advanced Fibrosis Detection for MASLD in Primary Care [NA]
A trial investigating advanced fibrosis detection for MASLD in primary care is currently recruiting. Sponsored by the Medical University of …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis [Phase 2]
A Phase 2 clinical trial evaluating S-adenosyl-L-methionine (SAMe) for prevention of liver cancer in MASLD-related cirrhosis; recruitment no…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
A clinical trial update indicates a non-invasive testing approach is being studied to assess major liver-related outcomes in MASLD, with enr…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women [NA]
This clinical trials update describes a study investigating the effects of circadian exercise on metabolic dysfunction-associated steatotic …
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease [NA]
A feasibility study by Baylor College of Medicine is evaluating the Paso Program for patients with metabolic dysfunction-associated steatoti…